Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (141-150 of 471) with videos related to

Pageof 48
Sort By:
Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.
American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
American Journal of Hematology|July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification ProductsSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Blood|June 3, 2006
Immunoglobulin free light chains and solitary plasmacytoma of boneDavid Dingli, Robert A Kyle, S Vincent Rajkumar, et al.
Blood Cancer Journal|May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk CytogeneticsRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Pageof 48

Showing results (141-150 of 471) with videos related to

Sort By:
Pageof 48
Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.
American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
American Journal of Hematology|July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification ProductsSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Blood|June 3, 2006
Immunoglobulin free light chains and solitary plasmacytoma of boneDavid Dingli, Robert A Kyle, S Vincent Rajkumar, et al.
Blood Cancer Journal|May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk CytogeneticsRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Pageof 48